Supplemental material
Pathogens and Global Health
Volume 112, 2018 - Issue 8
Open access
2,435
Views
8
CrossRef citations to date
0
Altmetric
Original Articles
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
Kathy BelkHealth Clarity Solutions, Mooresville, NC, USAView further author information
, Mark P. ConnollyDepartment of Pharmacy, Unit of Pharmacoepidemiology & Pharmacoeconomics, University of Groningen, Groningen, The Netherlands;Global Market Access Solutions LLC, Mooresville, NC, USACorrespondence[email protected] [email protected]
http://orcid.org/0000-0002-1886-745XView further author information
, http://orcid.org/0000-0002-1886-745XView further author information
Lisa SchlesingerSage Therapeutics, Cambridge, MA, USAView further author information
& Ruben R. Ben-HarariDepartment of Medical Affairs, Vyera Pharmaceuticals, New York, NY, USAhttp://orcid.org/0000-0001-6531-2409View further author information
Pages 428-437
|
Published online: 10 Dec 2018
Related Research Data
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
Source:
Figshare
Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.